Evidence to Impact: Treating Large HCC Tumors with TheraSphere™ Y-90 Glass Microspheres

Sponsored by Boston Scientific

Join Dr. Tyler Sandow for an expert-led discussion on how TheraSphere™ Y-90 is redefining treatment for large hepatocellular carcinoma (HCC) tumors. This session will highlight the latest clinical data, explore the importance of radiation per microsphere (RPM), and demonstrate how optimized dose delivery drives tumor response while preserving healthy tissue. Real-world case examples will bring the science to life, offering insights into how high-dose, high-RPM therapy is delivering results where it matters most. 

Presenter: 
Tyler Sandow, MD
Ochsner Medical Center, New Orleans, LA 
Interventional Radiologist